Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.40382155 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.69833655 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.69833655 |
4 | negative regulation of cell killing (GO:0031342) | 6.64886659 |
5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.64886659 |
6 | positive thymic T cell selection (GO:0045059) | 6.57071067 |
7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.48030232 |
8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.16102392 |
9 | negative T cell selection (GO:0043383) | 6.07794673 |
10 | negative thymic T cell selection (GO:0045060) | 5.98188049 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 5.90541096 |
12 | positive T cell selection (GO:0043368) | 5.88104335 |
13 | thymic T cell selection (GO:0045061) | 5.66084727 |
14 | regulation of T cell tolerance induction (GO:0002664) | 5.52974097 |
15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.51116091 |
16 | T cell selection (GO:0045058) | 5.44037171 |
17 | response to interleukin-15 (GO:0070672) | 5.29351767 |
18 | tolerance induction (GO:0002507) | 5.04109987 |
19 | leukocyte aggregation (GO:0070486) | 4.84650605 |
20 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.80282361 |
21 | positive regulation of tolerance induction (GO:0002645) | 4.79275684 |
22 | T cell migration (GO:0072678) | 4.75425603 |
23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.65906176 |
24 | regulation of regulatory T cell differentiation (GO:0045589) | 4.65248114 |
25 | interferon-gamma production (GO:0032609) | 4.50139779 |
26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.48040443 |
27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.48040443 |
28 | modulation by symbiont of host immune response (GO:0052553) | 4.48040443 |
29 | positive regulation by symbiont of host defense response (GO:0052509) | 4.48040443 |
30 | modulation by symbiont of host defense response (GO:0052031) | 4.48040443 |
31 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.48040443 |
32 | T cell receptor signaling pathway (GO:0050852) | 4.47458875 |
33 | detection of bacterium (GO:0016045) | 4.44407568 |
34 | cellular response to interleukin-15 (GO:0071350) | 4.42504767 |
35 | detection of other organism (GO:0098543) | 4.39035995 |
36 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.19533523 |
37 | regulation of tolerance induction (GO:0002643) | 4.15467883 |
38 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.14769333 |
39 | B cell receptor signaling pathway (GO:0050853) | 3.99881795 |
40 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.97786158 |
41 | regulation of B cell differentiation (GO:0045577) | 3.95660568 |
42 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.95383654 |
43 | T cell costimulation (GO:0031295) | 3.94183251 |
44 | neutrophil activation involved in immune response (GO:0002283) | 3.89976324 |
45 | lymphocyte costimulation (GO:0031294) | 3.86605484 |
46 | response to muramyl dipeptide (GO:0032495) | 3.81053962 |
47 | positive regulation of interleukin-2 production (GO:0032743) | 3.76519714 |
48 | activated T cell proliferation (GO:0050798) | 3.75058842 |
49 | positive regulation of B cell differentiation (GO:0045579) | 3.70674386 |
50 | macrophage activation involved in immune response (GO:0002281) | 3.68139246 |
51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.67565641 |
52 | T cell homeostasis (GO:0043029) | 3.66574689 |
53 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.57659011 |
54 | positive regulation of histone deacetylation (GO:0031065) | 3.52787531 |
55 | response to peptidoglycan (GO:0032494) | 3.52435149 |
56 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.50081353 |
57 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.48713273 |
58 | NIK/NF-kappaB signaling (GO:0038061) | 3.45035812 |
59 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.44011088 |
60 | immunoglobulin mediated immune response (GO:0016064) | 3.40720175 |
61 | leukocyte cell-cell adhesion (GO:0007159) | 3.38970169 |
62 | detection of external biotic stimulus (GO:0098581) | 3.36727797 |
63 | positive regulation of isotype switching (GO:0045830) | 3.36391195 |
64 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.34294897 |
65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.33902163 |
66 | regulation of isotype switching (GO:0045191) | 3.33005156 |
67 | cellular response to type I interferon (GO:0071357) | 3.32614497 |
68 | type I interferon signaling pathway (GO:0060337) | 3.32614497 |
69 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.31073428 |
70 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.29639915 |
71 | lymphocyte homeostasis (GO:0002260) | 3.29293901 |
72 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.26800412 |
73 | natural killer cell differentiation (GO:0001779) | 3.25409722 |
74 | germinal center formation (GO:0002467) | 3.25201727 |
75 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.23523302 |
76 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.23208176 |
77 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.20519814 |
78 | respiratory burst (GO:0045730) | 3.16417803 |
79 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.12659302 |
80 | neutrophil activation (GO:0042119) | 3.12481609 |
81 | regulation of interleukin-2 production (GO:0032663) | 3.10393649 |
82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.10374469 |
83 | negative regulation of innate immune response (GO:0045824) | 3.08409296 |
84 | regulation of response to interferon-gamma (GO:0060330) | 3.06320842 |
85 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.05794656 |
86 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.02516459 |
87 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.02157433 |
88 | regulation of mast cell degranulation (GO:0043304) | 3.01872926 |
89 | myeloid cell activation involved in immune response (GO:0002275) | 2.99964186 |
90 | mannose metabolic process (GO:0006013) | 2.99223443 |
91 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.98792781 |
92 | response to host immune response (GO:0052572) | 2.98792781 |
93 | defense response to protozoan (GO:0042832) | 2.98478218 |
94 | alpha-beta T cell activation (GO:0046631) | 2.97048610 |
95 | histone H3-K4 trimethylation (GO:0080182) | 2.94045672 |
96 | negative regulation of interleukin-12 production (GO:0032695) | 2.93053039 |
97 | detection of biotic stimulus (GO:0009595) | 2.91884952 |
98 | positive regulation of granulocyte differentiation (GO:0030854) | 2.91703651 |
99 | response to host (GO:0075136) | 2.91285794 |
100 | response to host defenses (GO:0052200) | 2.91285794 |
101 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.91285794 |
102 | B cell homeostasis (GO:0001782) | 2.89089785 |
103 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.88954858 |
104 | mast cell activation (GO:0045576) | 2.87651977 |
105 | T cell differentiation (GO:0030217) | 2.87368610 |
106 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.86676904 |
107 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.86452372 |
108 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.86099089 |
109 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.86099089 |
110 | negative regulation of phagocytosis (GO:0050765) | 2.85926072 |
111 | regulation of leukocyte degranulation (GO:0043300) | 2.84525173 |
112 | granulocyte activation (GO:0036230) | 2.82780914 |
113 | leukocyte homeostasis (GO:0001776) | 2.82776348 |
114 | natural killer cell activation (GO:0030101) | 2.81260982 |
115 | regulation of granulocyte differentiation (GO:0030852) | 2.80865757 |
116 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.78737875 |
117 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.78246591 |
118 | leukocyte degranulation (GO:0043299) | 2.77450940 |
119 | negative regulation of interleukin-6 production (GO:0032715) | 2.76989938 |
120 | positive regulation of DNA recombination (GO:0045911) | 2.76858855 |
121 | T cell proliferation (GO:0042098) | 2.76636719 |
122 | alpha-beta T cell differentiation (GO:0046632) | 2.76489915 |
123 | regulation of B cell mediated immunity (GO:0002712) | 2.76483253 |
124 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.76360767 |
125 | signal complex assembly (GO:0007172) | 2.75854034 |
126 | response to protozoan (GO:0001562) | 2.75820580 |
127 | mast cell activation involved in immune response (GO:0002279) | 2.74653257 |
128 | mast cell degranulation (GO:0043303) | 2.74653257 |
129 | positive regulation of T cell differentiation (GO:0045582) | 2.74481468 |
130 | positive regulation of protein deacetylation (GO:0090312) | 2.73186611 |
131 | response to laminar fluid shear stress (GO:0034616) | 2.73109954 |
132 | heterotypic cell-cell adhesion (GO:0034113) | 2.72744537 |
133 | regulation of immunoglobulin production (GO:0002637) | 2.72350067 |
134 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.72225199 |
135 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.67310288 |
136 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.67310288 |
137 | positive regulation of humoral immune response (GO:0002922) | 2.64791725 |
138 | negative regulation of B cell mediated immunity (GO:0002713) | 2.63225843 |
139 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.63225843 |
140 | positive regulation of immunoglobulin production (GO:0002639) | 2.63104791 |
141 | regulation of alpha-beta T cell activation (GO:0046634) | 2.61687089 |
142 | cellular extravasation (GO:0045123) | 2.60592544 |
143 | response to type I interferon (GO:0034340) | 2.60581280 |
144 | positive regulation of B cell mediated immunity (GO:0002714) | 2.60409372 |
145 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.60409372 |
146 | histone H3-K4 methylation (GO:0051568) | 2.60218656 |
147 | T cell activation (GO:0042110) | 2.59690072 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.37634273 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.90779315 |
3 | MYC_22102868_ChIP-Seq_BL_Human | 4.33649933 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.71990603 |
5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.25842359 |
6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.21589755 |
7 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.09967220 |
8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.08596147 |
9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.05099234 |
10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.00182497 |
11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.98006837 |
12 | MAF_26560356_Chip-Seq_TH1_Human | 2.90943498 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.82693857 |
14 | MYB_26560356_Chip-Seq_TH2_Human | 2.80190951 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.77760294 |
16 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.71021353 |
17 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.58160938 |
18 | MYB_26560356_Chip-Seq_TH1_Human | 2.57755012 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.46797513 |
20 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.43067667 |
21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.42874533 |
22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.37510889 |
23 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.30345900 |
24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.28956197 |
25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.23491876 |
26 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.22089879 |
27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18195363 |
28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.16664389 |
29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15939727 |
30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.12651043 |
31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.10054702 |
32 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05699334 |
33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03468249 |
34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.01471463 |
35 | * MAF_26560356_Chip-Seq_TH2_Human | 1.99604092 |
36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.98145277 |
37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.92351963 |
38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.90666081 |
39 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90113235 |
40 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.87046994 |
41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81457984 |
42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75526641 |
43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.74205197 |
44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68523887 |
45 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.68465690 |
46 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.67366379 |
47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51213480 |
48 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.49069491 |
49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.45252896 |
50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43725543 |
51 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43361821 |
52 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37525620 |
53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36967147 |
54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36325823 |
55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28140926 |
56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.27628420 |
57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26238643 |
58 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.25430739 |
59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25270344 |
60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23046112 |
61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21197314 |
62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.21092002 |
63 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20320169 |
64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18523233 |
65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15889287 |
66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15787981 |
67 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15696328 |
68 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13501083 |
69 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.10916997 |
70 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10757857 |
71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09406622 |
72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09045370 |
73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08940980 |
74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08416095 |
75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06285269 |
76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06210403 |
77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05698921 |
78 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04043197 |
79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02033310 |
80 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99773049 |
81 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98584892 |
82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98203685 |
83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98005987 |
84 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.97282307 |
85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97217666 |
86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96705742 |
87 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95581167 |
88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94996939 |
89 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94504775 |
90 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92341191 |
91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92100146 |
92 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92025913 |
93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91889242 |
94 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91651625 |
95 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.90928017 |
96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90592448 |
97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90316687 |
98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90016621 |
99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89551484 |
100 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89544557 |
101 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.89110702 |
102 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88266828 |
103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85645887 |
104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84433570 |
105 | P68_20966046_ChIP-Seq_HELA_Human | 0.84281235 |
106 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.82376411 |
107 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82047371 |
108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81861974 |
109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81807595 |
110 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81277777 |
111 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.80124505 |
112 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.79427784 |
113 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79426475 |
114 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79089952 |
115 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.78071354 |
116 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.77858110 |
117 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.77645359 |
118 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.77583067 |
119 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.75425231 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 4.54203969 |
2 | MP0000685_abnormal_immune_system | 3.62143796 |
3 | MP0001790_abnormal_immune_system | 3.30422663 |
4 | MP0005387_immune_system_phenotype | 3.30422663 |
5 | MP0001835_abnormal_antigen_presentation | 3.26174307 |
6 | * MP0001800_abnormal_humoral_immune | 3.21414022 |
7 | MP0005671_abnormal_response_to | 3.11431182 |
8 | MP0002396_abnormal_hematopoietic_system | 2.79028179 |
9 | MP0001873_stomach_inflammation | 2.78376386 |
10 | MP0003303_peritoneal_inflammation | 2.72274090 |
11 | * MP0002398_abnormal_bone_marrow | 2.68382626 |
12 | MP0005000_abnormal_immune_tolerance | 2.67672999 |
13 | * MP0002420_abnormal_adaptive_immunity | 2.64813395 |
14 | MP0003300_gastrointestinal_ulcer | 2.63086829 |
15 | * MP0002723_abnormal_immune_serum | 2.60664344 |
16 | * MP0001819_abnormal_immune_cell | 2.60135458 |
17 | * MP0002452_abnormal_antigen_presenting | 2.59919754 |
18 | MP0003436_decreased_susceptibility_to | 2.46490099 |
19 | MP0002166_altered_tumor_susceptibility | 2.43158429 |
20 | MP0000703_abnormal_thymus_morphology | 2.38898442 |
21 | * MP0000716_abnormal_immune_system | 2.33665987 |
22 | MP0002405_respiratory_system_inflammati | 2.28596065 |
23 | MP0004947_skin_inflammation | 2.28019981 |
24 | MP0009333_abnormal_splenocyte_physiolog | 2.21188133 |
25 | * MP0002722_abnormal_immune_system | 2.19039102 |
26 | * MP0000689_abnormal_spleen_morphology | 2.18688283 |
27 | MP0005025_abnormal_response_to | 2.17359761 |
28 | MP0003866_abnormal_defecation | 2.15150025 |
29 | MP0010155_abnormal_intestine_physiology | 2.10469653 |
30 | MP0004808_abnormal_hematopoietic_stem | 2.08014957 |
31 | MP0009278_abnormal_bone_marrow | 2.02598855 |
32 | MP0009785_altered_susceptibility_to | 1.96342670 |
33 | MP0005464_abnormal_platelet_physiology | 1.94283696 |
34 | * MP0002429_abnormal_blood_cell | 1.92953697 |
35 | MP0000465_gastrointestinal_hemorrhage | 1.92646821 |
36 | MP0008260_abnormal_autophagy | 1.91264597 |
37 | MP0002006_tumorigenesis | 1.83988346 |
38 | * MP0002419_abnormal_innate_immunity | 1.82536723 |
39 | MP0004510_myositis | 1.80444154 |
40 | MP0006082_CNS_inflammation | 1.68523015 |
41 | MP0002933_joint_inflammation | 1.65672651 |
42 | MP0001845_abnormal_inflammatory_respons | 1.61362518 |
43 | MP0002148_abnormal_hypersensitivity_rea | 1.60390663 |
44 | MP0005451_abnormal_body_composition | 1.59210004 |
45 | MP0005397_hematopoietic_system_phenotyp | 1.52732019 |
46 | MP0001545_abnormal_hematopoietic_system | 1.52732019 |
47 | MP0010352_gastrointestinal_tract_polyps | 1.49839568 |
48 | MP0001853_heart_inflammation | 1.47476935 |
49 | MP0003724_increased_susceptibility_to | 1.43317877 |
50 | MP0008961_abnormal_basal_metabolism | 1.42436886 |
51 | MP0000490_abnormal_crypts_of | 1.27662676 |
52 | MP0005076_abnormal_cell_differentiation | 1.23693250 |
53 | MP0001851_eye_inflammation | 1.20345524 |
54 | MP0005310_abnormal_salivary_gland | 1.19251610 |
55 | MP0000858_altered_metastatic_potential | 1.17574266 |
56 | MP0005023_abnormal_wound_healing | 1.15230139 |
57 | MP0001533_abnormal_skeleton_physiology | 1.12063723 |
58 | MP0003566_abnormal_cell_adhesion | 1.08382541 |
59 | MP0005174_abnormal_tail_pigmentation | 1.07242595 |
60 | MP0004883_abnormal_blood_vessel | 1.04673269 |
61 | MP0008469_abnormal_protein_level | 1.02965302 |
62 | MP0002019_abnormal_tumor_incidence | 1.00878048 |
63 | MP0003448_altered_tumor_morphology | 0.98657379 |
64 | MP0004185_abnormal_adipocyte_glucose | 0.97626615 |
65 | MP0003045_fibrosis | 0.89193422 |
66 | MP0005390_skeleton_phenotype | 0.84168851 |
67 | MP0001986_abnormal_taste_sensitivity | 0.84131949 |
68 | MP0003690_abnormal_glial_cell | 0.82000276 |
69 | MP0005166_decreased_susceptibility_to | 0.81551461 |
70 | MP0003091_abnormal_cell_migration | 0.81412377 |
71 | MP0003453_abnormal_keratinocyte_physiol | 0.79561710 |
72 | MP0005075_abnormal_melanosome_morpholog | 0.78560345 |
73 | MP0000569_abnormal_digit_pigmentation | 0.78086019 |
74 | MP0003191_abnormal_cellular_cholesterol | 0.77547928 |
75 | MP0003172_abnormal_lysosome_physiology | 0.77143754 |
76 | MP0002277_abnormal_respiratory_mucosa | 0.75407139 |
77 | MP0003077_abnormal_cell_cycle | 0.74937596 |
78 | MP0003279_aneurysm | 0.74215193 |
79 | MP0005164_abnormal_response_to | 0.72695235 |
80 | MP0003705_abnormal_hypodermis_morpholog | 0.72066497 |
81 | MP0002138_abnormal_hepatobiliary_system | 0.71954637 |
82 | MP0002998_abnormal_bone_remodeling | 0.71914475 |
83 | MP0005670_abnormal_white_adipose | 0.68440174 |
84 | MP0002132_abnormal_respiratory_system | 0.68228212 |
85 | MP0001348_abnormal_lacrimal_gland | 0.67567870 |
86 | MP0003075_altered_response_to | 0.67524988 |
87 | MP0001663_abnormal_digestive_system | 0.67202283 |
88 | MP0000609_abnormal_liver_physiology | 0.66263420 |
89 | MP0005058_abnormal_lysosome_morphology | 0.65528579 |
90 | MP0003828_pulmonary_edema | 0.65336161 |
91 | MP0004381_abnormal_hair_follicle | 0.64518966 |
92 | MP0009763_increased_sensitivity_to | 0.63120501 |
93 | MP0000477_abnormal_intestine_morphology | 0.62561189 |
94 | MP0004130_abnormal_muscle_cell | 0.62253217 |
95 | MP0000604_amyloidosis | 0.62100183 |
96 | MP0000733_abnormal_muscle_development | 0.61592859 |
97 | MP0002136_abnormal_kidney_physiology | 0.60896367 |
98 | MP0001243_abnormal_dermal_layer | 0.60240961 |
99 | MP0010307_abnormal_tumor_latency | 0.58920402 |
100 | MP0008004_abnormal_stomach_pH | 0.57803743 |
101 | MP0001216_abnormal_epidermal_layer | 0.56460379 |
102 | MP0001958_emphysema | 0.56175192 |
103 | MP0005381_digestive/alimentary_phenotyp | 0.55768506 |
104 | MP0000350_abnormal_cell_proliferation | 0.53752974 |
105 | MP0000015_abnormal_ear_pigmentation | 0.53702666 |
106 | MP0009931_abnormal_skin_appearance | 0.52752639 |
107 | MP0009764_decreased_sensitivity_to | 0.52690881 |
108 | MP0000313_abnormal_cell_death | 0.51530577 |
109 | MP0003693_abnormal_embryo_hatching | 0.50839769 |
110 | MP0003183_abnormal_peptide_metabolism | 0.50471685 |
111 | MP0003795_abnormal_bone_structure | 0.50459599 |
112 | MP0002009_preneoplasia | 0.49881477 |
113 | MP0001849_ear_inflammation | 0.49635305 |
114 | MP0000249_abnormal_blood_vessel | 0.49446502 |
115 | MP0009115_abnormal_fat_cell | 0.49060211 |
116 | MP0008057_abnormal_DNA_replication | 0.48715496 |
117 | MP0009840_abnormal_foam_cell | 0.48615891 |
118 | MP0005666_abnormal_adipose_tissue | 0.48445631 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 5.46781981 |
2 | Abnormality of T cell number (HP:0011839) | 5.17018319 |
3 | Panhypogammaglobulinemia (HP:0003139) | 4.74266497 |
4 | Abnormality of the fingertips (HP:0001211) | 4.65381570 |
5 | Chronic otitis media (HP:0000389) | 4.58992879 |
6 | Recurrent viral infections (HP:0004429) | 4.56513089 |
7 | Abnormality of macrophages (HP:0004311) | 4.48801364 |
8 | Recurrent bronchitis (HP:0002837) | 4.38776774 |
9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.38235520 |
10 | Recurrent fungal infections (HP:0002841) | 4.34986072 |
11 | Pustule (HP:0200039) | 4.33738038 |
12 | Nasal polyposis (HP:0100582) | 4.22503426 |
13 | Abnormality of T cells (HP:0002843) | 4.13362439 |
14 | IgM deficiency (HP:0002850) | 4.07020331 |
15 | Orchitis (HP:0100796) | 4.00789342 |
16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.82297022 |
17 | Optic neuritis (HP:0100653) | 3.74708107 |
18 | Retrobulbar optic neuritis (HP:0100654) | 3.74708107 |
19 | Abnormality of the nasal mucosa (HP:0000433) | 3.74022933 |
20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.72636716 |
21 | Autoimmune thrombocytopenia (HP:0001973) | 3.70923871 |
22 | Agammaglobulinemia (HP:0004432) | 3.68953098 |
23 | Eczematoid dermatitis (HP:0000976) | 3.60447954 |
24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.57875359 |
25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.57875359 |
26 | Severe combined immunodeficiency (HP:0004430) | 3.57016076 |
27 | Inflammation of the large intestine (HP:0002037) | 3.53934879 |
28 | Gastrointestinal inflammation (HP:0004386) | 3.50180800 |
29 | Papilloma (HP:0012740) | 3.49828027 |
30 | Verrucae (HP:0200043) | 3.49828027 |
31 | Combined immunodeficiency (HP:0005387) | 3.49386278 |
32 | Stomatitis (HP:0010280) | 3.35058110 |
33 | Colitis (HP:0002583) | 3.22964052 |
34 | B lymphocytopenia (HP:0010976) | 3.11469778 |
35 | Abnormality of B cell number (HP:0010975) | 3.11469778 |
36 | Spontaneous hematomas (HP:0007420) | 3.09927547 |
37 | Cellulitis (HP:0100658) | 3.05459016 |
38 | Lymphopenia (HP:0001888) | 3.03330461 |
39 | Meningitis (HP:0001287) | 3.01927398 |
40 | Eosinophilia (HP:0001880) | 3.01597697 |
41 | Autoimmune hemolytic anemia (HP:0001890) | 2.98061641 |
42 | Recurrent abscess formation (HP:0002722) | 2.97451873 |
43 | Abnormality of T cell physiology (HP:0011840) | 2.95710548 |
44 | Thyroiditis (HP:0100646) | 2.95222961 |
45 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.92857690 |
46 | Prolonged bleeding time (HP:0003010) | 2.91080300 |
47 | Increased IgE level (HP:0003212) | 2.88252240 |
48 | IgG deficiency (HP:0004315) | 2.77564172 |
49 | Myositis (HP:0100614) | 2.76636653 |
50 | Abnormality of eosinophils (HP:0001879) | 2.75923830 |
51 | Basal cell carcinoma (HP:0002671) | 2.74476373 |
52 | Keratoconjunctivitis sicca (HP:0001097) | 2.73704385 |
53 | Granulocytopenia (HP:0001913) | 2.72809308 |
54 | Urticaria (HP:0001025) | 2.71600412 |
55 | Leukocytosis (HP:0001974) | 2.69360557 |
56 | Chronic sinusitis (HP:0011109) | 2.61582160 |
57 | Emphysema (HP:0002097) | 2.61298793 |
58 | Hypochromic anemia (HP:0001931) | 2.57636832 |
59 | Recurrent skin infections (HP:0001581) | 2.55513107 |
60 | Papilledema (HP:0001085) | 2.55199296 |
61 | Vasculitis (HP:0002633) | 2.52804952 |
62 | Recurrent bacterial skin infections (HP:0005406) | 2.52693355 |
63 | Recurrent sinusitis (HP:0011108) | 2.52130710 |
64 | Chronic diarrhea (HP:0002028) | 2.51300081 |
65 | Keratoconjunctivitis (HP:0001096) | 2.49038130 |
66 | Gastrointestinal stroma tumor (HP:0100723) | 2.45348803 |
67 | Mediastinal lymphadenopathy (HP:0100721) | 2.44948594 |
68 | Increased IgM level (HP:0003496) | 2.40077994 |
69 | Bronchitis (HP:0012387) | 2.38380132 |
70 | Cerebral aneurysm (HP:0004944) | 2.38056161 |
71 | IgA deficiency (HP:0002720) | 2.35667351 |
72 | Increased density of long bones (HP:0006392) | 2.31291830 |
73 | Abnormal platelet volume (HP:0011876) | 2.31227453 |
74 | Epistaxis (HP:0000421) | 2.29109682 |
75 | Thrombocytosis (HP:0001894) | 2.25187730 |
76 | Aortic aneurysm (HP:0004942) | 2.24935855 |
77 | Pulmonary embolism (HP:0002204) | 2.24918525 |
78 | Slow saccadic eye movements (HP:0000514) | 2.24485407 |
79 | Viral hepatitis (HP:0006562) | 2.23431362 |
80 | Episodic fever (HP:0001954) | 2.21255631 |
81 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.19015942 |
82 | Petechiae (HP:0000967) | 2.15294439 |
83 | Arterial thrombosis (HP:0004420) | 2.14715056 |
84 | Obstructive sleep apnea (HP:0002870) | 2.14128251 |
85 | Hypoplasia of the thymus (HP:0000778) | 2.14055276 |
86 | Ureteral stenosis (HP:0000071) | 2.13517337 |
87 | Lymphoma (HP:0002665) | 2.13246088 |
88 | Chest pain (HP:0100749) | 2.12883464 |
89 | Hypochromic microcytic anemia (HP:0004840) | 2.09158619 |
90 | Periodontitis (HP:0000704) | 2.08331081 |
91 | Chronic obstructive pulmonary disease (HP:0006510) | 2.07197266 |
92 | Obstructive lung disease (HP:0006536) | 2.07197266 |
93 | Skin ulcer (HP:0200042) | 2.06533800 |
94 | Joint swelling (HP:0001386) | 2.04577181 |
95 | Recurrent otitis media (HP:0000403) | 2.02115457 |
96 | Abnormal platelet function (HP:0011869) | 2.01839456 |
97 | Impaired platelet aggregation (HP:0003540) | 2.01839456 |
98 | Hemoptysis (HP:0002105) | 2.00248405 |
99 | Hyperacusis (HP:0010780) | 2.00183199 |
100 | Anorexia (HP:0002039) | 2.00172479 |
101 | Interstitial pulmonary disease (HP:0006530) | 1.99632128 |
102 | Premature loss of primary teeth (HP:0006323) | 1.98582916 |
103 | Broad face (HP:0000283) | 1.94652935 |
104 | Abnormality of the pleura (HP:0002103) | 1.94506566 |
105 | Cheilitis (HP:0100825) | 1.93813735 |
106 | Gingival bleeding (HP:0000225) | 1.93434158 |
107 | Bicuspid aortic valve (HP:0001647) | 1.93128223 |
108 | Ureteral obstruction (HP:0006000) | 1.92764453 |
109 | Polygenic inheritance (HP:0010982) | 1.91229157 |
110 | Restrictive lung disease (HP:0002091) | 1.91060648 |
111 | Encephalitis (HP:0002383) | 1.90874865 |
112 | Purpura (HP:0000979) | 1.90590691 |
113 | Frequent falls (HP:0002359) | 1.90089770 |
114 | Hematochezia (HP:0002573) | 1.89158590 |
115 | Increased serum ferritin (HP:0003281) | 1.88943293 |
116 | Seborrheic dermatitis (HP:0001051) | 1.87860870 |
117 | Broad palm (HP:0001169) | 1.87708921 |
118 | Villous atrophy (HP:0011473) | 1.86677246 |
119 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.86677246 |
120 | Microcytic anemia (HP:0001935) | 1.85066765 |
121 | Glomerulopathy (HP:0100820) | 1.85033441 |
122 | Dysostosis multiplex (HP:0000943) | 1.84630137 |
123 | Gingivitis (HP:0000230) | 1.83036238 |
124 | Increased mean platelet volume (HP:0011877) | 1.82495287 |
125 | Abnormality of the peritoneum (HP:0002585) | 1.80890173 |
126 | Peritonitis (HP:0002586) | 1.79188538 |
127 | Macroorchidism (HP:0000053) | 1.77207970 |
128 | Sepsis (HP:0100806) | 1.76890654 |
129 | Pulmonary infiltrates (HP:0002113) | 1.76811619 |
130 | Hepatitis (HP:0012115) | 1.75311679 |
131 | Osteomyelitis (HP:0002754) | 1.75157747 |
132 | Gastrointestinal infarctions (HP:0005244) | 1.75008326 |
133 | Hypergammaglobulinemia (HP:0010702) | 1.74647302 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 5.73921231 |
2 | PRPF4B | 3.56205446 |
3 | TXK | 3.12098147 |
4 | MAP3K10 | 3.07182727 |
5 | STK10 | 2.79196774 |
6 | JAK3 | 2.77755607 |
7 | EEF2K | 2.70484823 |
8 | GRK6 | 2.63888901 |
9 | TYK2 | 2.54366238 |
10 | ZAP70 | 2.52543107 |
11 | FGFR4 | 2.46863625 |
12 | ITK | 2.37142944 |
13 | TRIB3 | 2.05234096 |
14 | SIK2 | 2.04488494 |
15 | PKN2 | 1.97741822 |
16 | MAP3K13 | 1.90621544 |
17 | IKBKE | 1.88019368 |
18 | JAK1 | 1.79984225 |
19 | CDK12 | 1.77781868 |
20 | ERN1 | 1.66384354 |
21 | BTK | 1.63500025 |
22 | FGFR3 | 1.63350448 |
23 | LCK | 1.62504411 |
24 | SMG1 | 1.56210739 |
25 | MAP3K14 | 1.52922267 |
26 | HCK | 1.51003366 |
27 | LRRK2 | 1.47671760 |
28 | NLK | 1.46837611 |
29 | SYK | 1.46751994 |
30 | MARK3 | 1.46106964 |
31 | CSK | 1.45890279 |
32 | TTN | 1.36335629 |
33 | BLK | 1.34958159 |
34 | TBK1 | 1.34328929 |
35 | MAP3K3 | 1.28049030 |
36 | EPHB1 | 1.25909350 |
37 | PRKCH | 1.24667158 |
38 | TGFBR2 | 1.23953759 |
39 | MAP3K7 | 1.17143545 |
40 | MAP3K11 | 1.17039788 |
41 | CDC42BPA | 1.12767044 |
42 | TEC | 1.12682744 |
43 | CSF1R | 1.08948344 |
44 | MAP2K3 | 1.07604948 |
45 | KIT | 1.07168788 |
46 | PTK6 | 1.05777105 |
47 | SIK1 | 1.05337901 |
48 | IRAK4 | 1.04445089 |
49 | MAP3K1 | 1.02209190 |
50 | FGR | 1.01411808 |
51 | CLK1 | 0.99216785 |
52 | FES | 0.98096709 |
53 | RPS6KA4 | 0.97239358 |
54 | PIM1 | 0.95317302 |
55 | PRKCQ | 0.92353678 |
56 | IKBKB | 0.91640312 |
57 | PRKD2 | 0.88385777 |
58 | KDR | 0.87360161 |
59 | CAMKK1 | 0.86393082 |
60 | PASK | 0.84971499 |
61 | CDK4 | 0.83817344 |
62 | BRD4 | 0.83217875 |
63 | TNK2 | 0.82040659 |
64 | KSR2 | 0.81662223 |
65 | NEK2 | 0.80260062 |
66 | TAOK1 | 0.78610681 |
67 | CHUK | 0.78503875 |
68 | MARK2 | 0.76799636 |
69 | PDGFRB | 0.74880145 |
70 | TAOK2 | 0.70970579 |
71 | ALK | 0.70773211 |
72 | LYN | 0.70233913 |
73 | SIK3 | 0.70050804 |
74 | ICK | 0.68231632 |
75 | CAMK1G | 0.67856342 |
76 | HIPK2 | 0.67791596 |
77 | TYRO3 | 0.66307141 |
78 | PDPK1 | 0.65609261 |
79 | FLT3 | 0.63918611 |
80 | YES1 | 0.62497499 |
81 | STK4 | 0.61952418 |
82 | TESK2 | 0.59934518 |
83 | MAP3K6 | 0.58332133 |
84 | * JAK2 | 0.55979308 |
85 | RPS6KC1 | 0.55877949 |
86 | RPS6KL1 | 0.55877949 |
87 | MAPK12 | 0.55517579 |
88 | IRAK1 | 0.55234344 |
89 | CAMK1D | 0.54464846 |
90 | CDK6 | 0.54408998 |
91 | RIPK4 | 0.54227947 |
92 | TRPM7 | 0.53618794 |
93 | FGFR2 | 0.53316301 |
94 | PDK1 | 0.53089680 |
95 | MST4 | 0.52761618 |
96 | MAP2K2 | 0.51138472 |
97 | MAPK7 | 0.50743247 |
98 | IRAK3 | 0.50474355 |
99 | NME2 | 0.50381123 |
100 | IRAK2 | 0.50143032 |
101 | EPHA3 | 0.49315847 |
102 | CAMKK2 | 0.48725369 |
103 | STK38 | 0.48074548 |
104 | DYRK1B | 0.46457495 |
105 | MELK | 0.46357034 |
106 | BMX | 0.44925601 |
107 | BMPR2 | 0.43938571 |
108 | MTOR | 0.43779582 |
109 | DMPK | 0.41553128 |
110 | RPS6KB2 | 0.40271631 |
111 | CDK9 | 0.40167025 |
112 | MAPK11 | 0.39859714 |
113 | MAP3K8 | 0.39740670 |
114 | TAOK3 | 0.38412899 |
115 | SGK3 | 0.37636735 |
116 | MAPK4 | 0.37102115 |
117 | PTK2B | 0.35887928 |
118 | STK11 | 0.35198285 |
119 | MAP2K6 | 0.35184767 |
120 | MAPKAPK2 | 0.34703066 |
121 | RPS6KA6 | 0.33840789 |
122 | FYN | 0.32831923 |
123 | PRKD1 | 0.32498825 |
124 | INSR | 0.31858101 |
125 | EGFR | 0.31400140 |
126 | RIPK1 | 0.31004023 |
127 | ABL1 | 0.27793179 |
128 | RET | 0.27561045 |
129 | PDGFRA | 0.27558498 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.08162030 |
2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.17627995 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.84626689 |
4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.44276333 |
5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.32628476 |
6 | Measles_Homo sapiens_hsa05162 | 2.29931241 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.26147729 |
8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.20113826 |
9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.18185370 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.10290776 |
11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.08105497 |
12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.07306674 |
13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.91514023 |
14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.81923158 |
15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69053947 |
16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.67952527 |
17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.61844162 |
18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.61748568 |
19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60669544 |
20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.57470408 |
21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53539499 |
22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51917677 |
23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48575585 |
24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48165201 |
25 | Hepatitis B_Homo sapiens_hsa05161 | 1.40199381 |
26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.33850288 |
27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.31907639 |
28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.31258619 |
29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.25540776 |
30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23178997 |
31 | Influenza A_Homo sapiens_hsa05164 | 1.22703793 |
32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19893556 |
33 | Shigellosis_Homo sapiens_hsa05131 | 1.19847526 |
34 | * Platelet activation_Homo sapiens_hsa04611 | 1.17308095 |
35 | HTLV-I infection_Homo sapiens_hsa05166 | 1.16958603 |
36 | Apoptosis_Homo sapiens_hsa04210 | 1.13317254 |
37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12438143 |
38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11551052 |
39 | Lysine degradation_Homo sapiens_hsa00310 | 1.11072914 |
40 | Colorectal cancer_Homo sapiens_hsa05210 | 1.10716129 |
41 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09762682 |
42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.08794544 |
43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.08454402 |
44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.04998011 |
45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04829869 |
46 | Allograft rejection_Homo sapiens_hsa05330 | 1.02631956 |
47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.01339856 |
48 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.00374887 |
49 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.95570504 |
50 | Tuberculosis_Homo sapiens_hsa05152 | 0.95431431 |
51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94845291 |
52 | Hepatitis C_Homo sapiens_hsa05160 | 0.93672937 |
53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91956876 |
54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90395182 |
55 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.88649602 |
56 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87505793 |
57 | Insulin resistance_Homo sapiens_hsa04931 | 0.85585658 |
58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82830422 |
59 | Malaria_Homo sapiens_hsa05144 | 0.82665259 |
60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82620564 |
61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81855081 |
62 | Phagosome_Homo sapiens_hsa04145 | 0.81514443 |
63 | Pertussis_Homo sapiens_hsa05133 | 0.76566645 |
64 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75818009 |
65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72669363 |
66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70888506 |
67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69641300 |
68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68084893 |
69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67213068 |
70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66986993 |
71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66841354 |
72 | Salmonella infection_Homo sapiens_hsa05132 | 0.65662473 |
73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64835967 |
74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63952337 |
75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63671631 |
76 | Legionellosis_Homo sapiens_hsa05134 | 0.62948487 |
77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62452463 |
78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61986087 |
79 | Prostate cancer_Homo sapiens_hsa05215 | 0.61806939 |
80 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60356096 |
81 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60246212 |
82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58977594 |
83 | Endocytosis_Homo sapiens_hsa04144 | 0.58733281 |
84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58596634 |
85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58384807 |
86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58363424 |
87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57623665 |
88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57037666 |
89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55729561 |
90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54742147 |
91 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54111382 |
92 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53253518 |
93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51377049 |
94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51352903 |
95 | Lysosome_Homo sapiens_hsa04142 | 0.51048567 |
96 | Spliceosome_Homo sapiens_hsa03040 | 0.49963321 |
97 | Focal adhesion_Homo sapiens_hsa04510 | 0.48377247 |
98 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47867774 |
99 | Glioma_Homo sapiens_hsa05214 | 0.47267939 |
100 | Amoebiasis_Homo sapiens_hsa05146 | 0.47242783 |
101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47201007 |
102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47085647 |
103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46843492 |
104 | Base excision repair_Homo sapiens_hsa03410 | 0.46686017 |
105 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.46668800 |
106 | Adherens junction_Homo sapiens_hsa04520 | 0.45436877 |
107 | ABC transporters_Homo sapiens_hsa02010 | 0.44983107 |
108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44657603 |
109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43959449 |
110 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.43951651 |
111 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.43792457 |
112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42918553 |
113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41950864 |
114 | Asthma_Homo sapiens_hsa05310 | 0.41185382 |
115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39221596 |
116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38503375 |
117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37070418 |
118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36979111 |